Journal: bioRxiv
Article Title: A GluN2B disease-associated variant promotes degradation of NMDA receptors via autophagy
doi: 10.1101/2025.01.12.632651
Figure Lengend Snippet: (A) Structure of the rat tetrameric GluN1_GluN2B NMDA receptor in complex with glutamate, with the GluN1 subunit in gray, and the GluN2B subunit in blue (PDB:9ARI) . The amino-terminal domain (ATD), ligand-binding domain (LBD), and transmembrane domain (TMD) are shown in ribbon format with the R519 residue selected for study in yellow spheres. (B) Residues involved in the glutamate binding site of the WT GluN2B subunit are represented a sticks, with the glutamate ligand in pink (upper). Mutagenesis of the R519 residue to a glutamine eliminates the electrostatic interaction with glutamate (lower). (C) Effects of R519Q on total GluN2B protein expression levels 48 hrs post transient transfection of HEK293T with GluN1 and GluN2B constructs at a 1:1 ratio to express WT or GluN2B_R519Q variant NMDARs (n=7). β-actin serves as the soluble total protein loading control. ( D) Surface biotinylation assay to monitor the influence of the R519Q DAV on the surface expression of NMDARs 48 hrs post transient transfection. Na + /K + ATPase served as a membrane protein loading control (n=8). (E) HEK293T cells stably expressing WT or R519Q GluN2B NMDARs were subjected to cyclohexmide (100 µg/mL) for the indicated times to determine the stability and rate of degradation (n=5). (F) Immunofluorescence images of GluN2B (green) and calnexin (red) an ER marker to assess ER accumulation (scale bar = 20 μm). Pearson’s coefficients are reported (n>30) and statistical significance was determined using a Mann-Whitney test. All data normalized to the appropriate loading control and data are presented as mean ± SEM. Statistical significance was determined using an unpaired two-tailed Student’s t-test between two groups or an analysis of variance (ANOVA) followed by a post-hoc Dunnett’s test for comparison in multiple groups. Significance level defined as *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
Article Snippet: The pcDNA3.1-GRIN1 (OHu22255D, NM_007327, human) and the pcDNA3.1-GRIN2B (OHu26128D, NM_000834, human) and pcDNA3.1-CCPG1 (OHu07897C, NM_004748.5) were obtained from GenScript.
Techniques: Ligand Binding Assay, Residue, Binding Assay, Mutagenesis, Expressing, Transfection, Construct, Variant Assay, Control, Surface Biotinylation Assay, Membrane, Stable Transfection, Immunofluorescence, Marker, MANN-WHITNEY, Two Tailed Test, Comparison